Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

International Flavors & Fragrances Inc a un objectif de cours consensus de $86.9, basé sur les évaluations des 23 analystes. Le plus élevé est de $112 attribué par Jefferies le janvier 12, 2024, et le plus bas est de $60 attribué par Redburn Atlantic le octobre 12, 2023. Les 3 dernières évaluations d'analystes ont été publiées par B of A Securities, Argus Research et UBS le octobre 14, 2025, octobre 7, 2025 et octobre 6, 2025. Avec un objectif de cours moyen de $72 entre B of A Securities, Argus Research et UBS, il y a une variation implicite de 11.06% upside pour International Flavors & Fragrances Inc à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/14/2025 | 23.4% | B of A Securities | $84 → $80 | Maintains | Buy | |||
10/07/2025 | 7.97% | Argus Research | $85 → $70 | Maintains | Buy | |||
10/06/2025 | 1.8% | UBS | $71 → $66 | Maintains | Neutral | |||
10/06/2025 | 15.69% | Citigroup | $82 → $75 | Maintains | Buy | |||
10/03/2025 | 15.69% | Mizuho | $85 → $75 | Maintains | Outperform | |||
09/22/2025 | 38.82% | Morgan Stanley | $92 → $90 | Maintains | Overweight | |||
09/08/2025 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
08/26/2025 | 61.96% | Tigress Financial | $105 → $105 | Maintains | Buy | |||
08/08/2025 | 20.31% | Barclays | $84 → $78 | Maintains | Overweight | |||
08/07/2025 | 31.11% | Wells Fargo | $90 → $85 | Maintains | Overweight | |||
08/06/2025 | 21.86% | UBS | $83 → $79 | Maintains | Neutral | |||
06/04/2025 | 61.96% | Tigress Financial | → $105 | Initiates | → Buy | |||
05/13/2025 | 51.16% | Morgan Stanley | $100 → $98 | Maintains | Overweight | |||
05/08/2025 | 38.82% | Citigroup | $84 → $90 | Maintains | Buy | |||
05/08/2025 | 54.25% | Baird | $110 → $100 | Maintains | Outperform | |||
05/08/2025 | 29.57% | Barclays | $76 → $84 | Upgrade | Equal-Weight → Overweight | |||
05/07/2025 | 28.03% | UBS | $82 → $83 | Maintains | Neutral | |||
04/22/2025 | 37.28% | Oppenheimer | $104 → $89 | Maintains | Outperform | |||
04/15/2025 | 34.2% | Mizuho | $95 → $87 | Maintains | Outperform | |||
04/14/2025 | 17.23% | Barclays | $82 → $76 | Maintains | Equal-Weight | |||
04/10/2025 | 54.25% | Morgan Stanley | $106 → $100 | Maintains | Overweight | |||
04/10/2025 | 40.37% | Stifel | $105 → $91 | Maintains | Buy | |||
04/09/2025 | 38.82% | Wells Fargo | $105 → $90 | Maintains | Overweight | |||
04/08/2025 | 29.57% | Citigroup | $99 → $84 | Maintains | Buy | |||
03/27/2025 | 26.48% | Barclays | $83 → $82 | Maintains | Equal-Weight | |||
02/20/2025 | 60.42% | Oppenheimer | $114 → $104 | Maintains | Outperform | |||
02/20/2025 | 60.42% | JP Morgan | $107 → $104 | Maintains | Overweight | |||
02/20/2025 | 55.79% | B of A Securities | $105 → $101 | Maintains | Buy | |||
02/20/2025 | 61.96% | Wells Fargo | $115 → $105 | Maintains | Overweight | |||
02/03/2025 | 61.96% | Stifel | $113 → $105 | Maintains | Buy | |||
01/28/2025 | 75.84% | Oppenheimer | $117 → $114 | Maintains | Outperform | |||
01/17/2025 | 35.74% | Barclays | $90 → $88 | Maintains | Equal-Weight | |||
01/07/2025 | — | Argus Research | — | Upgrade | Hold → Buy | |||
12/18/2024 | 61.96% | Citigroup | $110 → $105 | Maintains | Buy | |||
11/12/2024 | 69.67% | Morgan Stanley | $111 → $110 | Upgrade | Equal-Weight → Overweight | |||
11/08/2024 | 65.05% | B of A Securities | $109 → $107 | Upgrade | Neutral → Buy | |||
11/07/2024 | 65.05% | JP Morgan | $110 → $107 | Maintains | Overweight | |||
11/07/2024 | 68.13% | Vertical Research | — | → $109 | Upgrade | Hold → Buy | ||
11/06/2024 | 71.22% | UBS | $108 → $111 | Maintains | Neutral | |||
10/24/2024 | 86.64% | Stifel | $115 → $121 | Maintains | Buy | |||
10/11/2024 | 52.71% | Barclays | $93 → $99 | Maintains | Equal-Weight | |||
09/11/2024 | 80.47% | Oppenheimer | $116 → $117 | Maintains | Outperform | |||
09/06/2024 | 69.67% | JP Morgan | $102 → $110 | Maintains | Overweight | |||
09/03/2024 | 85.1% | Mizuho | $109 → $120 | Upgrade | Neutral → Outperform | |||
08/15/2024 | 58.88% | UBS | $107 → $103 | Maintains | Neutral | |||
08/08/2024 | 57.33% | JP Morgan | $100 → $102 | Maintains | Overweight | |||
08/08/2024 | 77.39% | Wells Fargo | $110 → $115 | Maintains | Overweight | |||
08/07/2024 | 65.05% | UBS | $100 → $107 | Maintains | Neutral | |||
07/22/2024 | 77.39% | Stifel | $95 → $115 | Upgrade | Hold → Buy | |||
07/12/2024 | 78.93% | Citigroup | $108 → $116 | Maintains | Buy | |||
07/09/2024 | 54.25% | UBS | $95 → $100 | Maintains | Neutral | |||
07/03/2024 | 58.88% | Morgan Stanley | $100 → $103 | Maintains | Equal-Weight | |||
06/07/2024 | 78.93% | Oppenheimer | → $116 | Initiates | → Outperform | |||
05/21/2024 | 54.25% | Morgan Stanley | $100 → $100 | Downgrade | Overweight → Equal-Weight | |||
05/10/2024 | 52.71% | B of A Securities | $87 → $99 | Maintains | Neutral | |||
05/08/2024 | 66.59% | Citigroup | $100 → $108 | Maintains | Buy | |||
05/08/2024 | 43.45% | Barclays | $82 → $93 | Maintains | Equal-Weight | |||
05/08/2024 | 69.67% | Wells Fargo | $100 → $110 | Maintains | Overweight | |||
05/08/2024 | 54.25% | JP Morgan | $75 → $100 | Upgrade | Neutral → Overweight | |||
05/08/2024 | 69.67% | Baird | $100 → $110 | Maintains | Outperform | |||
05/07/2024 | 46.54% | Stifel | $87 → $95 | Maintains | Hold | |||
05/07/2024 | 51.16% | Mizuho | $91 → $98 | Maintains | Neutral | |||
04/12/2024 | 15.69% | Barclays | $69 → $75 | Maintains | Underweight | |||
04/10/2024 | 54.25% | Citigroup | $81 → $100 | Upgrade | Neutral → Buy | |||
04/04/2024 | 54.25% | Wells Fargo | $90 → $100 | Maintains | Overweight | |||
03/27/2024 | 48.08% | Morgan Stanley | $89 → $96 | Maintains | Overweight | |||
03/20/2024 | 54.25% | Deutsche Bank | $90 → $100 | Maintains | Buy | |||
03/20/2024 | 40.37% | Mizuho | $83 → $91 | Maintains | Neutral | |||
03/08/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Underperform | |||
02/26/2024 | 28.03% | Mizuho | $82 → $83 | Maintains | Neutral | |||
02/23/2024 | 24.94% | Citigroup | $85 → $81 | Maintains | Neutral | |||
02/22/2024 | 38.82% | Wells Fargo | $85 → $90 | Maintains | Overweight | |||
02/22/2024 | 31.11% | Baird | $80 → $85 | Maintains | Outperform | |||
02/21/2024 | 26.48% | Mizuho | $86 → $82 | Maintains | Neutral | |||
02/21/2024 | 23.4% | Stifel | $87 → $80 | Maintains | Hold | |||
01/22/2024 | 38.82% | Morgan Stanley | $81 → $90 | Upgrade | Equal-Weight → Overweight | |||
01/12/2024 | 6.43% | Barclays | $64 → $69 | Maintains | Underweight | |||
01/12/2024 | 72.76% | Jefferies | $73 → $112 | Upgrade | Hold → Buy | |||
01/11/2024 | 26.48% | UBS | $78 → $82 | Maintains | Neutral | |||
12/20/2023 | 34.2% | Stifel | $81 → $87 | Maintains | Hold | |||
12/06/2023 | 24.94% | Morgan Stanley | $75 → $81 | Maintains | Equal-Weight | |||
11/28/2023 | 31.11% | Argus Research | → $85 | Upgrade | Hold → Buy | |||
11/13/2023 | 20.31% | UBS | $88 → $78 | Downgrade | Buy → Neutral | |||
11/08/2023 | 31.11% | Wells Fargo | $80 → $85 | Maintains | Overweight | |||
11/07/2023 | 34.2% | Stifel | $77 → $87 | Maintains | Hold | |||
10/12/2023 | -12.08% | Barclays | $60 → $57 | Maintains | Underweight | |||
10/12/2023 | -7.45% | Redburn Atlantic | → $60 | Initiates | → Neutral | |||
09/14/2023 | 24.94% | Stifel | $81 → $81 | Reiterates | Hold → Hold | |||
08/24/2023 | 15.69% | Morgan Stanley | $112 → $75 | Downgrade | Overweight → Equal-Weight | |||
08/10/2023 | 20.31% | Goldman Sachs | $120 → $78 | Maintains | Neutral | |||
08/10/2023 | -7.45% | Barclays | $75 → $60 | Maintains | Underweight | |||
08/09/2023 | 3.35% | JP Morgan | $83 → $67 | Maintains | Neutral | |||
08/09/2023 | 31.11% | Deutsche Bank | $110 → $85 | Maintains | Buy | |||
08/09/2023 | 23.4% | Wells Fargo | $93 → $80 | Maintains | Overweight | |||
08/09/2023 | 20.31% | Goldman Sachs | $120 → $78 | Downgrade | Buy → Neutral | |||
08/09/2023 | 7.97% | Citigroup | $84 → $70 | Maintains | Neutral | |||
08/08/2023 | 46.54% | Credit Suisse | $110 → $95 | Maintains | Outperform | |||
08/08/2023 | 31.11% | Stifel | $123 → $85 | Downgrade | Buy → Hold | |||
07/18/2023 | 85.1% | Goldman Sachs | $134 → $120 | Maintains | Buy |
Le dernier objectif de prix pour Intl Flavors & Fragrances (NYSE:IFF) a été rapporté par B of A Securities le octobre 14, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $80.00 s'attendant à ce que IFF se rise dans les 12 prochains mois (un possible changement de 23.40% upside). 39 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Intl Flavors & Fragrances (NYSE:IFF) a été fournie par B of A Securities, et Intl Flavors & Fragrances maintenu leur note buy.
La dernière amélioration pour International Flavors & Fragrances Inc a eu lieu le septembre 8, 2025 lorsque Wolfe Research a augmenté leur objectif de prix à N/A. Wolfe Research avait précédemment an underperform pour International Flavors & Fragrances Inc.
La dernière réduction pour International Flavors & Fragrances Inc a eu lieu le mai 21, 2024 lorsque Morgan Stanley a changé leur objectif de prix de $100 à $100 pour International Flavors & Fragrances Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Intl Flavors & Fragrances, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Intl Flavors & Fragrances a été déposée le octobre 14, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 14, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Intl Flavors & Fragrances (IFF) était un maintenu avec un objectif de prix de $84.00 à $80.00. Le prix actuel de Intl Flavors & Fragrances (IFF) est de $64.83, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.